Gara I I
Zh Nevrol Psikhiatr Im S S Korsakova. 1993;93(3):28-32.
Pentoxifylline versus nicergoline therapy has been studied in 56 patients with atherosclerosis of major cerebral arteries who had ischemic apoplexy. Pentoxifylline enhances circulation primarily in the stenotic vessels, while nicergoline in the intact cerebral arteries. The former is more potent in inducing antiaggregation inhibiting spontaneous platelet and red cell aggregation and reducing blood viscosity. The results of the study suggest better response in case of pentoxifylline treatment of patients with hypo- and eukinetic circulation, while in nicergoline treatment hyperkinetic hemodynamics patients benefit more in view of the drug cardiodepressive activity.
已对56例患有大脑主要动脉粥样硬化并发生缺血性中风的患者进行了己酮可可碱与尼麦角林治疗的对比研究。己酮可可碱主要增强狭窄血管中的血液循环,而尼麦角林则作用于完整的脑动脉。前者在诱导抗聚集方面更有效,可抑制自发性血小板和红细胞聚集并降低血液粘度。研究结果表明,对于血液循环减退和动力不足的患者,己酮可可碱治疗的反应更好,而对于尼麦角林治疗,鉴于该药的心脏抑制活性,血液动力学亢进的患者受益更多。